Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates

被引:77
作者
Daly, MM [1 ]
Doktor, S [1 ]
Flamm, R [1 ]
Shortridge, D [1 ]
机构
[1] Abbott Labs, Infect Dis Res, Abbott Pk, IL 60064 USA
关键词
D O I
10.1128/jcm.42.8.3570-3574.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent work has shown that the efflux genes in Streptococcus pneumoniae that are responsible for acquired macrolide resistance can be distinguished as either mef(E) or mef(A). The genetic elements on which mef(A) and mef(E) are found also carry an open reading frame (ORF) that is 56% homologous to msr(A) in Staphylococcus. The prevalence of mef(A/E) and of the msr-like ORF [msr(D)] was evaluated in 153 mef(+) S. pneumoniae clinical isolates collected in North America, Europe, Africa, and Asia from 1997 to 2002. Clinical isolates were screened with PCR primers specific for either mef(A) or mef(E) and for msr(D). mef(A), mef(E), and msr(D) were cloned from mef(+) strains and transformed into a susceptible, competent strain of S. pneumoniae. The transformants were tested for antimicrobial susceptibilities and efflux pump induction. The results of this work demonstrated that mef(A) is more often isolated in parts of Europe, with some incidence in Canada, and that the msr-like gene alone can confer the efflux phenotype.
引用
收藏
页码:3570 / 3574
页数:5
相关论文
共 21 条
  • [1] THE AMI LOCUS OF THE GRAM-POSITIVE BACTERIUM STREPTOCOCCUS-PNEUMONIAE IS SIMILAR TO BINDING PROTEIN-DEPENDENT TRANSPORT OPERONS OF GRAM-NEGATIVE BACTERIA
    ALLOING, G
    TROMBE, MC
    CLAVERYS, JP
    [J]. MOLECULAR MICROBIOLOGY, 1990, 4 (04) : 633 - 644
  • [2] Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites
    Amezaga, MR
    Carter, PE
    Cash, P
    McKenzie, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) : 3313 - 3318
  • [3] Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes
    Clancy, J
    Petitpas, J
    DibHajj, F
    Yuan, W
    Cronan, M
    Kamath, AV
    Bergeron, J
    Retsema, JA
    [J]. MOLECULAR MICROBIOLOGY, 1996, 22 (05) : 867 - 879
  • [4] CONSTRUCTION AND EVALUATION OF NEW DRUG-RESISTANCE CASSETTES FOR GENE DISRUPTION MUTAGENESIS IN STREPTOCOCCUS-PNEUMONIAE, USING AN AMI TEST PLATFORM
    CLAVERYS, JP
    DINTILHAC, A
    PESTOVA, EV
    MARTIN, B
    MORRISON, DA
    [J]. GENE, 1995, 164 (01) : 123 - 128
  • [5] Epidemiology of infection - Pneumococci causing invasive disease in Britain 1982-1990
    Colman, G
    Cooke, EM
    Cookson, BD
    Cooper, PG
    Efstratiou, A
    George, RC
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (01) : 17 - 27
  • [6] Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae
    Del Grosso, M
    Iannelli, F
    Messina, C
    Santagati, M
    Petrosillo, N
    Stefani, S
    Pozzi, G
    Pantosti, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) : 774 - 778
  • [7] Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations
    Doktor, SZ
    Shortridge, VD
    Beyer, JM
    Flamm, RK
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 49 (01) : 47 - 52
  • [8] GUSAFFERO C, 1993, DIAGNOSTIC MOL MICRO, P584
  • [9] Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999:: Prevalence of mef(A) and erm(B) and susceptibilities to ketolides
    Hoban, DJ
    Wierzbowski, AK
    Nichol, K
    Zhanel, GG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) : 2147 - 2150
  • [10] Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae
    Jorgensen, JH
    Crawford, SA
    McElmeel, ML
    Whitney, CG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) : 605 - 607